Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison-Reference-Cited by-同舟云学术

Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison

Published:2013-09-19 Issue:2 Volume:53 Page:251-258
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Macchia Gabriella,Cilla Savino,Morganti Alessio Giuseppe,Deodato Francesco,Legge Francesco,Piermattei Angelo,Chiantera Vito,Scambia Giovanni,Valentini Vincenzo,Ferrandina Gabriella

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.819997

Reference24 articles.

1. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II—clinical results

2. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy

3. Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer

4. Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations;Gynecologic Oncology;2020-08

2. Dosimetric comparison of vaginal vault brachytherapy vs applicator-guided stereotactic body radiotherapy with volumetric modulated arc therapy and helical tomotherapy for endometrium cancer patients;Medical Dosimetry;2019

3. Does the Use of Volumetric Modulated Arc Therapy Reduce Gastrointestinal Symptoms after Pelvic Radiotherapy?;Clinical Oncology;2018-01

4. Radiotherapy in patients with HIV: current issues and review of the literature;The Lancet Oncology;2017-07

5. Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial;International Journal of Radiation Oncology*Biology*Physics;2016-11